Research, cases and webinars in tricuspid interventions

Alex Sticchi provides his take on the TRILUMINATE pivotal trial which was presented by David H. Adams at the TCT Congress 2022.

As the relationship between leaflet length and annular dimension becomes highly relevant in TR pathophysiology, the present study aimed to evaluate the impact of tricuspid leaflet-to-annulus mismatch on outcomes after T-TEER.

During #EuroPCR 2022, Alessandro Sticchi, member of the PCR Tricuspid group, interviewed several speakers on tricuspid interventions.

In this interview, João Cavalcante and Alessandro Sticchi discuss the evolving role and evolution of advanced imaging in tricuspid interventions.

Alessandro Sticchi asks Rebecca Hahn about the one-year results of the CLASP TR study and the impact it will have on the management of tricuspid regurgitation.

Philip Lurz speaks with Alessandro Sticchi about the 30-day results from the TriClip bRIGHT study on 300 subjects with symptomatic tricuspid regurgitation. He also shares his perspective on the future of edge to edge treatment in the tricuspid field.

Alessandro Sticchi and Luigi Biasco provide their take on the 1-year results of the CLASP TR study which were presented by Dr Adan Greenbaum, co-director of the Emory Structural Heart and Valve Center (Atlanta, GA) during the 2022 American College of Cardiology annual Congress held in Washington D.C.

An 81-year-old lady with past history of surgical aortic valve replacement followed by implantation of dual-chamber permanent pacemaker was admitted for recurrent episodes of right heart decompensations. The echocardiographic evaluation revealed massive TR and moderate primary MR due to a retracted posterior leaflet. What would be...

The authors hypothesized that disordered right ventricular to pulmonary artery (RV-PA) coupling may denote RV decompensation in patients undergoing transcatheter tricuspid valve repair (TTVR) that may correlate with poor clinical outcomes.

As the prognostic role of cardiohepatic syndrome (CHS) has not yet been evaluated, Stolz et al. in the present study assessed its impact on T-TEER outcomes.

A. Sticchi and J. Curio provide you with a summary of the studies that highlighted 2021 in the field of transcatheter tricuspid intervention: TRILUMINATE, CLASP TR EFS, EVOQUE TTVR, TRI-REPAIR, and more.

Alex Sticchi, interventional cardiologist, interviews Rebecca Hahn, Interventional Echocardiographer, about a recent State of the Art article about transcatheter treatment for tricuspid valve disease published in EuroIntervention.

They discuss the importance of starting with the classification of anatomy and that of secondary TR and identifying how clinical...

The development and successful results of transcatheter aortic valve implantation, followed by transcatheter therapies for mitral valve disease have opened a myriad of opportunities for transcatheter treatment of TR. Read this State-of-the-Art paper published in EuroIntervention by the PCR Tricuspid Focus Group.

The 6-month follow-up of the TRISCEND study was presented during the TCT Congress 2021 by principal investigator Susheel Kodali. Alessandro Sticchi & Jonathan Curio offer a review of this trial.

Alessandro Sticchi interviews Susheel Kodali, PI of the TRISCEND trial, presented at TCT 2021. They discuss the main results of the study, its impact on the field of Tricuspid and the upcoming TRISCEND II study.

Discover the replay of this PCR Webinar on tricuspid valve disease with F. Maisano, R. von Bardeleben, J. L. Zamorano, J. Cavalcante, P. Lurz and G. Nickenig. Learn about transcatheter tricuspid valve procedures, and more!

PCR Webinar with M. Metra, F. Praz, M. Sitges, E. Donal, R. Hahn, D. Muraru and Y. Topilsky

Watch the replay of this PCR Webinar on tricuspid valve management with L. Sondergaard, H. Treede, N. Wunderlich, L. Conradi, J. Hausleiter and A. Latib